Photo: Getty Images

The laser-like national focus on reining in the cost of certain prescription drugs is beginning to produce thoughtful responses from all parties, although the pharmaceutical manufacturers may be less than enthusiastic about much of the activity.

Among the most ambitious: a proposed new rule by the Centers for Medicare and Medicaid Services that would test different ways of managing the cost of very expensive drugs based upon performance criteria. It targets drugs that are distributed either in physicians’ offices or at hospitals, ones that tend to be expensive.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.